Catalyst Funds Management Pty LTD Dexcom Inc Transaction History
Catalyst Funds Management Pty LTD
- $409 Billion
- Q4 2024
A detailed history of Catalyst Funds Management Pty LTD transactions in Dexcom Inc stock. As of the latest transaction made, Catalyst Funds Management Pty LTD holds 10,200 shares of DXCM stock, worth $905,556. This represents 0.19% of its overall portfolio holdings.
Number of Shares
10,200Holding current value
$905,556% of portfolio
0.19%Shares
2 transactions
Others Institutions Holding DXCM
# of Institutions
1,079Shares Held
351MCall Options Held
8.45MPut Options Held
5.75M-
Vanguard Group Inc Valley Forge, PA46.5MShares$4.13 Billion0.06% of portfolio
-
Black Rock Inc. New York, NY34.5MShares$3.06 Billion0.09% of portfolio
-
State Street Corp Boston, MA16.7MShares$1.48 Billion0.05% of portfolio
-
Baillie Gifford & CO14.6MShares$1.3 Billion0.9% of portfolio
-
Capital Research Global Investors Los Angeles, CA14.4MShares$1.28 Billion0.24% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $34.3B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...